๐๐๐๐ฅ๐ญ๐ก ๐๐๐๐ซ๐๐ญ๐๐ซ๐ฒ ๐๐ง๐ ๐๐ ๐๐ฌ ๐๐ง๐ญ๐๐ซ๐ง๐๐ญ๐ข๐จ๐ง๐๐ฅ ๐๐๐๐๐ข๐ง๐ ๐๐ง๐ฌ๐ญ๐ข๐ญ๐ฎ๐ญ๐ ๐๐๐๐๐๐ซ๐ฌ ๐๐ญ ๐๐จ๐ซ๐ฅ๐ ๐๐ข๐จ ๐๐ฎ๐ฆ๐ฆ๐ข๐ญ
๐๐๐จ๐ฎ๐ฅ ๐๐จ๐ฎ๐ญ๐ก ๐๐จ๐ซ๐๐- ๐๐๐ญ๐ก ๐๐จ๐ฏ๐๐ฆ๐๐๐ซ ๐๐๐๐ -ย During the World Bio Summit in Seoul, Health Cabinet Secretary Nakhumicha S. Wafula engaged with the International Vaccine Institute (IVI) leadership, led by the Director General Mr. Jerome Kim, Mr. Junhee (Jaybrant) Lee, Business Development Manager, and Ms. Youngmi Cho, Head of Global Affairs and Communications.ย
Discussions centered on discovering, developing, and delivering safe, effective, and affordable vaccines for vulnerable populations worldwide.
The IVI's impactful strides in bolstering Korea's vaccine manufacturing, coupled with a strategic partnership between IVI and Kenya's BioVax Institute facilitated by the Kenyan government, signify a significant leap forward. This partnership focuses on technology transfer and manufacturing support, marking a monumental collaboration.
Kenya's commitment to hosting IVI's continental office underscores a promising future. This initiative is poised to forge crucial partnerships in technology and knowledge transfer, amplifying the nationโs readiness to combat vaccine-preventable diseases during outbreaks, epidemics, or pandemics.